Skip to main content
Log in

“Shaggy” aorta syndrome with atheromatous embolization to visceral vessels

  • Original Articles
  • Published:
Annals of Vascular Surgery

Abstract

Spontaneous atheromatous visceral embolization from diffuse aortic atherosclerotic disease is an unusual and poorly understood entity. We have reviewed our experience with 88 patients who suffered atheromatous embolization from a “shaggy” aorta. Visceral embolization was evident in 36 patients (40.9%). Nine were treated nonoperatively with three patients dying within a week of presentation and an additional five patients dying within five years due to continuing renal and intestinal embolization. Surgical correction was undertaken 28 times in 27 patients. Endarterectomy or graft replacement of the aorta did not necessarily prevent visceral infarction or renal failure. Extraanatomic bypass with ligation of the distal external iliac arteries appears to be associated with the lowest morbidity and mortality. Anticoagulation of these patients does not prevent embolization and may be contraindicated for long-term management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. KAZMIER FJ. Shaggy aorta syndrome and disseminated atheromatous embolization. In: BERGAN JJ, YAO JST (eds).Aortic Surgery. Philadelphia: W. B. Saunders Company, 1989, pp 189–194.

    Google Scholar 

  2. KASSIRER JP. Atheroembolic renal disease.N Engl J Med 1969;280:812–818.

    PubMed  Google Scholar 

  3. PANUM PL. Experimentelle beitrage zur lehre von der emboli.Virchows Arch Pathol Anat 1862;25:308–310.

    Google Scholar 

  4. KAZMIER FJ, SHEPS SG, BERNATZ PE, et al. Livedo reticularis and digital infarcts: a syndrome due to cholesterol emboli arising from atheromatous abdominal aortic aneurysms.Vasc Dis 1966;3:12–24.

    PubMed  Google Scholar 

  5. MOLDVEEN-GERONIMUS M, MERRIAM JC. Cholesterol embolization: from pathological curiosity to clinical entity.Circulation 1967;35:946–953.

    PubMed  Google Scholar 

  6. BRUNS FJ, SEGEL DP, ADLER S. Control of cholesterol embolization by discontinuation of anticoagulant therapy.Am J Med Sci 1978;275:105–108.

    PubMed  Google Scholar 

  7. KAZMIER FJ. Current practice with vitamin K antagonist therapy.Mayo Clin Proc 1974;49:918–921.

    PubMed  Google Scholar 

  8. FEDER W, AUERBACH R. “Purple toes”: an uncommon sequela of oral coumarin therapy.Ann Intern Med 1961;55:911–917.

    PubMed  Google Scholar 

  9. HYMAN BT, LANDAS SK, ASHMAN RF, et al. Warfarin-related purple toes syndrome and cholesterol microembolization.Am J Med 1987;82:1233–1237.

    Article  PubMed  Google Scholar 

  10. RAMIREZ G, O'NEILL WM Jr, LAMBERT R, et al. Cholesterol embolization. A complication of angiography.Arch Intern Med 1978;138:1430–1432.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Hollier, L.H., Kazmier, F.J., Ochsner, J. et al. “Shaggy” aorta syndrome with atheromatous embolization to visceral vessels. Annals of Vascular Surgery 5, 439–444 (1991). https://doi.org/10.1007/BF02133048

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02133048

Key words

Navigation